MedTrace Logo

Measuring Lactation Initiation After Early Postpartum Injectable Progestin (DMPA) Use Among Women in Dhanusha District of Nepal: A Pilot Study

NCT06816901 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-09-10

No results posted yet for this study

Summary

This is a pilot study of early postpartum initiation of the injectable progestin contraception, depo medroxyprogesterone acetate (DMPA), among 40 postpartum people. The study aims to assess the feasibility to conduct a larger trial evaluating the effects of early postpartum initiation DMPA on lactation and infant growth outcomes in Nepal.

Conditions

  • Postpartum Contraception
  • Depot Medroxyprogesterone Acetate
  • Lactation
  • DMPA

Interventions

DRUG

Depo Medroxyprogesterone acetate

Initiation of injectable depo medroxyprogesterone acetate (DMPA) contraception within 48 hours after birth

Sponsors & Collaborators

Principal Investigators

  • Sarah Averbach, MD, MAS · University of California, San Diego

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-26
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • Nepal

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06816901 on ClinicalTrials.gov